Dmitry Sharov

Dmitry Sharov has extensive experience in the clinical trials and biotechnology sectors, currently serving as CEO of OCT - Clinical Trials since 2005. In addition, Dmitry Sharov is the founder of Therapyte, which has been operating since January 2014. Prior to these roles, Dmitry Sharov was the CEO of GCT from February 2000 to February 2005.